You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Improved Transit Rider Experience

    SBC: MERCURY DATA SYSTEMS, INC.            Topic: 121FT1

    We propose to develop an advanced navigation solution for public transportation passengers that will guide them from their origin to single or multiple destination points and across multiple modes of transportation. Passengers will simply need to enter their destination (and optionally a starting point) and the system will select optimal and alternative routes. The navigation software will run on ...

    SBIR Phase I 2012 Department of Transportation
  2. Low Cost Stabilized Laser Diode System

    SBC: Ceebco, LLC            Topic: N/A

    This Phase 1 SBIR project aims to develop a frequency stabilized laser diode system suitable for application in optical metrology and in displacement measurement. The compact design of the semiconductor laser lends itself to many applications where a coherent light source is required, but space is at a premium. Some fields, such as precision optical metrology require a coherent light source whose ...

    SBIR Phase I 2012 Department of CommerceNational Institute of Standards and Technology
  3. Novel on-dose authentication to enhance pharmaceutical supply chain security

    SBC: CERTIRX CORPORATION            Topic: FDA

    DESCRIPTION (provided by applicant): The counterfeit drug business originated with lifestyle drugs, such as the erectile dysfunction drug. Now, however, counterfeits in almost any therapeutic category may be purchased by Americans through internet pharmacies. In fact, the Pharmaceutical Safety Institute found in 2010 that counterfeits in the metabolic disease category grew fastest (2), with the tr ...

    SBIR Phase I 2012 Department of Health and Human ServicesFood and Drug Administration
  4. Picture Me Alcohol Free: Engaging Youth in Community-Based Prevention

    SBC: PREVENTION STRATEGIES, LLC            Topic: NIAAA

    DESCRIPTION (provided by applicant): This application proposes to build on the successful Phase I Picture Me Alcohol Free (PMAF) feasibility pilot study. PMAF is a community-based program designed to train groups of youth to a) represent contributing factors and consequences (e.g., social availability, alcohol-involved crashes) of underage drinking in their communities through a specific photograp ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  5. A Needle Guidance System for Hepatic Tumor Ablation That Fuses Real-Time Ultrasou

    SBC: INNEROPTIC TECHNOLOGY INC            Topic: NCI

    DESCRIPTION (provided by applicant): We propose to develop an operating-room-ready system for needle guidance in soft tissue, which fuses intra- operative ultrasound and pre-operative X-ray computed tomography (CT) data by combining two novel technologies:1) a radically different way of visualizing and interacting with the fused ultrasound and CT images, which we call Spotlight ; and 2) an innova ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  6. Melanocortin Ligands in Disease Cachexia

    SBC: TENSIVE CONTROLS, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): Cachexia-anorexia syndrome is a life-threatening aspect to many diseases, in particular many forms of cancer or therapies for cancer. The obvious symptoms of this disease include lack of appetite, and a loss of lean body mass disproportionate to the reduction in caloric intake. However, the less obvious effects include multi-organ failure, due to high metabolic ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  7. Targeted Treatment of Recurrent Small Cell Lung Cancer with Anti-AbnV2 Antibodies

    SBC: Woomera Therapeutics, Inc.            Topic: NCI

    DESCRIPTION (provided by applicant): There is currently no effective treatment for recurrent small-cell lung cancer (rSCLC). The objective of this project is to utilize a monoclonal antibody, Abner, to develop new, rational, and successful treatment of rSCLC. The hypothesis being tested is that an abnormal vasopressin type 2 receptor (AbnV2R) present on these tumors will provide a sensitive, tumor ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  8. Targeting Oral Biofilms with 2-Aminoimidazole/Triazole Conjugates

    SBC: AGILE SCIENCES, INC.            Topic: NIDCR

    DESCRIPTION (provided by applicant): Dental caries is one of the most prevalent diseases in the U.S. with 85% of adults and the majority of children having been treated for at least one incidence. While this disease impacts all individuals, it is especially an issue for those of low economic status who have limited access to professional oral care. Dental caries is attributed to the presence of t ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  9. Improving Obesity Outcomes Through Interactive Web-Based Clinical Skills Training

    SBC: Clinical Tools, Inc            Topic: NIDDK

    DESCRIPTION (provided by applicant): The dire implications of the adult obesity epidemic grow worse over time. Despite front page coverage and universal agreement that the epidemic in weight gain and secondary disease establishment must be addressed, the problem continues. Intended Impact: We propose to improve outcomes of patients with obesity or at risk for obesity via a PC/mobile web-based prod ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  10. Peptide conjugation for Co-Delivery of Growth Factors and Stem Cells

    SBC: AFFINERGY, LLC            Topic: NIGMS

    DESCRIPTION (provided by applicant): Autologous stem cells and growth factors provide valuable therapies for a variety of indications. When stem cells and growth factors are co-delivered, they produce a greater therapeutic effect than delivery of either stem cells or growth factors alone. However, the use of growth factors in the clinic is limited by the challenges of retaining the proteins at th ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government